• Kaempferol, NRF2, and Inflammatory Osteolysis

  2026-09-10

  A 2026 study identifies NRF2 as a direct molecular target of kaempferol in osteoclasts and links NRF2/HO-1 activation to reduced oxidative stress, osteoclastogenesis, and inflammatory bone loss. Genetic NRF2 depletion and the NRF2 inhibitor ML385 weakened kaempferol’s effects, providing a useful pharmacological framework for testing pathway dependence in osteoclast and immune-microenvironment models.

• SETD7 Depletion Promotes White Adipose Browning

  2026-09-10

  This study identifies SETD7 as a negative regulator of inguinal white adipose tissue thermogenesis in obese mice. Genetic or cellular SETD7 depletion enhanced beige-fat activity through an Adcy7–Sirt1–CREB1 signaling axis, increased energy expenditure, and improved high-fat-diet metabolic outcomes.

• TAK-715 Workflow for p38 MAPK Studies

  2026-09-09

  TAK-715 is a selective p38α-focused tool for separating pathway inhibition from broader cytotoxic or stress effects. This practical workflow connects solvent handling, phospho-signaling assays, cytokine measurements, and inflammation models to improve experimental confidence.

• iPSC Organoids Model Pan-Genotype HEV Infection

  2026-09-09

  This study establishes induced pluripotent stem cell-derived liver, intestinal and brain organoids as multicellular models supporting complete propagation of clinical HEV genotypes 1, 3 and 4. The platform connects viral tropism with organ-specific injury, barrier disruption and neuronal responses, while providing a physiologically relevant system for antiviral evaluation.

• TAK-715: Practical p38 MAPK Inhibition Workflows

  2026-09-08

  TAK-715 combines nanomolar p38α activity with a workflow-friendly profile for dissecting cytokine signaling, stress responses, and inflammatory phenotypes. This guide connects cell-based assays, mechanistic dephosphorylation studies, and rheumatoid arthritis research while emphasizing controls, dosing logic, and troubleshooting.

• Haloprogin: Designing Better Antimicrobial Assays

  2026-09-08

  Haloprogin is more than a historical topical antifungal: its contrasting MIC, MFC, matrix, and in vivo findings create a framework for designing interpretable antimicrobial assays. This article shows how to translate those data into rigorous dermatophyte, Candida, and Gram-positive research workflows.

• EVMPs for Extrahepatic mRNA Delivery

  2026-09-07

  The reference study presents a bottom-up, self-assembling enveloped virus-mimicking particle (EVMP) that delivers mRNA beyond the liver by combining engineered peptides with tunable phospholipid envelopes. Its strongest evidence is lung and spleen targeting, including substantial transfection of lung endothelial and immune cells, while repeated-dose and biosafety results support further evaluation of the platform.

• Diuron: Mechanism, Toxicology & Research Use

  2026-09-07

  Diuron, also called 3-(3,4-dichlorophenyl)-1,1-dimethylurea, is a chlorophenyl urea herbicide and photosynthesis inhibitor. Recent network toxicology and cell experiments connect Diuron exposure with JAK2/STAT1 activation and acute kidney injury mechanisms, while product specifications support controlled laboratory use.

• SN-38: From TOP1 Inhibition to Translational Strategy

  2026-09-05

  7-Ethyl-10-hydroxycamptothecin, also known as SN-38, offers translational researchers a mechanistically defined benchmark for studying topoisomerase I inhibition, replication-associated damage, cell-cycle arrest, apoptosis, and the FUBP1/FUSE regulatory axis in cancer models.

• Annexin V-FITC/PI Apoptosis Assay Kit Guide

  2026-09-04

  A scenario-driven guide to selecting, running, and interpreting the Annexin V-FITC/PI Apoptosis Assay Kit, with practical recommendations for flow cytometry apoptosis detection and microscopy. SKU K2003 supports rapid two-marker discrimination of viable, early apoptotic, late apoptotic, and membrane-compromised cells.

• Neticonazole Hydrochloride: Dual-Action Profile

  2026-09-04

  Neticonazole Hydrochloride is an imidazole antifungal with reported activity against fungal cell membrane synthesis and emerging colorectal cancer research applications. The product dossier describes topical antifungal use and a separate animal-model oncology signal, while the cited nanomedicine study provides delivery context rather than direct evidence for neticonazole.

• PPT: Selective ERα Agonist for Research

  2026-09-03

  PPT, or Propyl Pyrazole Triol, is a potent and selective ERα agonist for separating estrogen receptor alpha signaling from ERβ activity. Product data report approximately 410-fold ERα selectivity, cellular ERα-mediated gene-expression effects, and activity in a uterotrophic assay.

• BMX-IN-1 Workflows for BMX Kinase Research

  2026-09-03

  Build mechanism-focused assays around BMX-IN-1 to connect covalent BMX inhibition with cell-cycle control, apoptosis induction, and lysosomal acidification. The workflow also shows how to adapt a cancer-oriented BMX kinase inhibitor for carefully controlled host-pathogen studies without overstating compound-specific evidence.

• TAK-715: p38 MAPK Inhibitor Workflow

  2026-09-02

  TAK-715 combines nanomolar p38α activity with a practical workflow for dissecting cytokine responses, inflammatory signaling, and rheumatoid arthritis research models. This guide connects concentration planning, time-resolved phospho-assays, and the latest structural insight into p38α dephosphorylation without assuming that every p38 inhibitor has the same mechanism.

• ML385: Practical NRF2 Inhibitor Workflows

  2026-09-02

  ML385 provides a selective way to test whether NRF2 activity drives antioxidant defense, ferroptosis resistance, inflammation, or chemotherapy response. This workflow-focused guide covers assay design, concentration planning, mechanistic controls, and troubleshooting across cancer and oxidative stress models.

8151 records 1/544 page Next 12345 下5页 Last page